InvestorsHub Logo

$heff

10/04/14 10:32 AM

#83424 RE: $heff #83148

$TGTX..The link to the full poster from the Pan Pacific Lymphoma Conference can be found at: http://www.tgtxinc.com/EPPLC2014-Poster2014.PDF.

"A Phase I Trial Of Ublituximab, A Novel Glycoengineered Anti-CD20 mAb, In Combination With TGR-1202, A Next Generation
PI3Kd Inhibitor, In Patients With Chronic Lymphocytic Leukemia And Non-Hodgkin’s Lymphoma"